ApprovalTrail

Approval · Notice of Compliance 5066 · 1995

ROFERON-A: Notice of Compliance 5066

Issued June 21, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5066
Date
June 21, 1995
Company
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indication: cutaneous T-cell lymphoma
Therapeutic class
Biological response modifier

Products in this notice

BrandDINStatus today
ROFERON-A00812501Cancelled Post Market
ROFERON-A02019914Cancelled Post Market
ROFERON-A00812498Cancelled Post Market
ROFERON-A00891002Cancelled Post Market
ROFERON-A00812471—

Medicinal ingredients